Skip to content

A clinical trial to study the effects of two manual physiotherapy techniques, MFR and MET used with pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

comparative effect of Myofascial release therapy versus Muscle energy technique as an adjunct to pulmonary rehabilitation on respiratory mechanics, functional exercise capacity, and quality of life in chronic obstructive pulmonary disease (COPD)- A randomized controlled trial - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107229
Enrollment
50
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecified

Interventions

Intervention1: Group A (MFR) , Group B (MET): Group A: Myofascial Release Technique (MFR) + Pulmonary Rehabilitation Participants receive myofascial release to the diaphragm, sternocleidomastoid, and

Sponsors

JAMIA HAMDARD
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Participants with diagnosed COPD (Stage II-Stage III) 2 Stable medical condition (no exacerbations in the last three month) 3 Willingness to participate in the study

Exclusion criteria

Exclusion criteria: 1 History of recent thoracic or abdominal surgery 2 Patients with severe orthopedic problems related to spine, fracture of rib 3 Unstable cardiac condition recent myocardial infarction , cor pulmonale etc. 4 Cognitive impairment preventing study participation 5 Subject participation in yoga, gym activities, and physical fitness training activities 6 Active lung disease which are contraindicated for exercise training , Skin related disorder of upper back and chest 7 Uncontrolled diabetes, uncontrolled hypertension 8 Musculoskeletal disorders affecting movement

Design outcomes

Primary

MeasureTime frame
1.Pulmonary Function Tests: FEV1, FVC, FEV1/FVC RATIO, MVV, PEFR 2.Chest Expansion MeasurementTimepoint: baseline , immediate , 2 weeks , 4 weeks

Secondary

MeasureTime frame
1.Functional capacity 2.dyspnea 3. quality of life 4.thoracic rotation Timepoint: baseline , immediate , 2 weeks , 4 weeks

Countries

India

Contacts

Public ContactJyoti Ganai

jamia hamdard university

Nahid0409@jamiahamdard.ac.in9582385008

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026